Literature DB >> 10204852

De novo deletion (14)(q11.2q13) including PAX9: clinical and molecular findings.

S Schuffenhauer1, H J Leifheit, P Lichtner, H Peters, J Murken, P Emmerich.   

Abstract

A 3 year old boy with a de novo deletion (14)(q11.2q13) of paternal origin encompassing the region from D14S264 to D14S70 is described. The patient presented with severe psychomotor retardation, bilateral cleft lip/palate, bilateral colobomas of the optic nerves and retinas, agenesis of the corpus callosum, pes calcaneovarus, reduced oesophageal peristalsis, and swallowing difficulties. This is the first reported case of PAX9 hemizygosity in humans. Haploinsufficiency of the PAX9 gene might be expected to cause some of the developmental defects and the dysphagia. Another haploinsufficiency candidate gene, the bZIP transcription factor gene NRL, which is specifically expressed in neuronal cells and the eye during embryogenesis, was excluded from the deletion interval.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10204852      PMCID: PMC1734334     

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  17 in total

1.  Novel proximal 14q deletion: clinical and diffusion tensor imaging tractography findings in a patient with lissencephaly, agenesis of the corpus callosum, and septo-optic dysplasia.

Authors:  E K Bravo; M L White; A H Olney; J L McAllister; Y D Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

2.  Molecular Diagnostics and In Utero Therapeutics for Orofacial Clefts.

Authors:  J D Oliver; E C Turner; L R Halpern; S Jia; P Schneider; R N D'Souza
Journal:  J Dent Res       Date:  2020-07-01       Impact factor: 6.116

Review 3.  Cochlear Implantation Outcomes in Children with Agenesis of the Corpus Callosum: A Retrospective Study and A Review of the Literature.

Authors:  Süleyman Özdemir; Ülkü Tuncer; Özgür Sürmelioğlu; Özgür Tarkan; Fikret Çelik; Mete Kıroğlu; Muhammed Dağkıran; Poyraz Şahin; Nilay Tezer; Funda Akar
Journal:  J Int Adv Otol       Date:  2019-12       Impact factor: 1.017

4.  Haploinsufficiency of novel FOXG1B variants in a patient with severe mental retardation, brain malformations and microcephaly.

Authors:  Sarah A Shoichet; Stella-Amrei Kunde; Petra Viertel; Can Schell-Apacik; Hubertus von Voss; Niels Tommerup; Hans-Hilger Ropers; Vera M Kalscheuer
Journal:  Hum Genet       Date:  2005-08-17       Impact factor: 4.132

Review 5.  A FOXG1 mutation in a boy with congenital variant of Rett syndrome.

Authors:  Tangui Le Guen; Nadia Bahi-Buisson; Juliette Nectoux; Nathalie Boddaert; Yann Fichou; Bertrand Diebold; Isabelle Desguerre; Florence Raqbi; Valérie Cormier Daire; Jamel Chelly; Thierry Bienvenu
Journal:  Neurogenetics       Date:  2010-08-24       Impact factor: 2.660

6.  Pulmonary pathology in thyroid transcription factor-1 deficiency syndrome.

Authors:  Csaba Galambos; Hara Levy; Carolyn L Cannon; Sara O Vargas; Lynne M Reid; Robert Cleveland; Robert Lindeman; Daphne E deMello; Susan E Wert; Jeffrey A Whitsett; Antonio R Perez-Atayde; Harry Kozakewich
Journal:  Am J Respir Crit Care Med       Date:  2010-03-04       Impact factor: 21.405

7.  Unbalanced X; autosome translocation.

Authors:  Neerja Gupta; Himanshu Goel; Shubha R Phadke
Journal:  Indian J Pediatr       Date:  2006-09       Impact factor: 1.967

8.  Genetic association studies of cleft lip and/or palate with hypodontia outside the cleft region.

Authors:  Rebecca L Slayton; Laura Williams; Jeffrey C Murray; James J Wheeler; Andrew C Lidral; Carla J Nishimura
Journal:  Cleft Palate Craniofac J       Date:  2003-05

9.  Cleft lip and palate genetics and application in early embryological development.

Authors:  Wenli Yu; Maria Serrano; Symone San Miguel; L Bruno Ruest; Kathy K H Svoboda
Journal:  Indian J Plast Surg       Date:  2009-10

10.  Disruption of Fgf10/Fgfr2b-coordinated epithelial-mesenchymal interactions causes cleft palate.

Authors:  Ritva Rice; Bradley Spencer-Dene; Elaine C Connor; Amel Gritli-Linde; Andrew P McMahon; Clive Dickson; Irma Thesleff; David P C Rice
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.